Photodynamic Diagnosis and Therapy in Dermatology

The topical application of δ-aminolevulinic acid (ALA) induces porphyrin formation in the skin, preferentially in tumor tissues. Irradiation of the porphyrin-enriched tumor tissue with Wood’s light leads to emission of a brick-red fluorescence. This principle may be used as a diagnostic procedure which may be termed photodynamic diagnosis (PDD). In ALA-PDD, tumors and precancerous lesions of the skin reveal a homogeneous, intensive red fluorescence. Psoriatic lesions also show a strong but inhomogeneous porphyrin fluorescence. ALA-induced porphyrin fluorescence in preoperative planning is a valuable method to determine the peripheral borders of a given tumor. The histopathological extensions of the tumors correlate well with the borders detected by the tumor-specific fluorescence. The main indications of PDD are the delineation of clinically ill-defined skin tumors and the control of the efficacy of other tumor therapies. Photodynamic therapy (PDT) utilizes exogenously applied or endogenously formed photosensitizers and their activation by light to induce cell death via formation of singlet oxygen and other free radicals. PDT is highly efficient in the treatment of solar keratoses and superficial basal cell carcinomas. Initial squamous cell carcinomas also show good response to ALA-PDT. During the last decade, numerous studies on PDT for dermatologic diseases were published, the more important ones are reviewed here.

[1]  T. Ruzicka,et al.  Ex vivo Application of δ‐Aminolevulinic Acid Induces High and Specific Porphyrin Levels in Human Skin Tumors: Possible Basis for Selective Photodynamic Therapy , 1997, Photochemistry and photobiology.

[2]  J H McColl,et al.  Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. , 1998, Archives of dermatology.

[3]  T. Mang,et al.  Photodynamic therapy in the management of neoplasms of the perianal skin. , 1992, Archives of surgery.

[4]  Julia G. Levy,et al.  Nononcologic potentials for photodynamic therapy , 1994, Other Conferences.

[5]  P. Calzavara-Pinton,et al.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.

[6]  T. Ruzicka,et al.  Successful Surgery of Multiple Recurrent Basal Cell Carcinomas Guided by Photodynamic Diagnosis , 1997, Aesthetic Plastic Surgery.

[7]  T. Dougherty,et al.  Photoradiation therapy for cutaneous and subcutaneous malignancies. , 1981, The Journal of investigative dermatology.

[8]  H. C. Robertson,et al.  Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms , 1968, Journal of the South Carolina Medical Association.

[9]  R. Anderson,et al.  Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. , 1995, Archives of dermatology.

[10]  J Moan,et al.  Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. , 1996, Journal of Photochemistry and Photobiology. B: Biology.

[11]  F. Gamarra,et al.  Photodynamic eradication of amelanotic melanoma of the hamster with fast acting photosensitizers , 1996, International journal of cancer.

[12]  W. Sterry,et al.  Treatment of psoriasis by topical photodynamic therapy with polychromatic light , 1994, The Lancet.

[13]  A. Leunig,et al.  Die photodynamische Lasertherapie im Bereich der Hals-, Nasen-, Ohrenheilkunde* , 1993 .

[14]  H Kerl,et al.  Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.

[15]  H. Pass,et al.  Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.

[16]  H. Meffert,et al.  [Photodynamic therapy of psoriasis palmaris et plantaris using a topically applied hematoporphyrin derivative and visible light]. , 1989, Dermatologische Monatschrift.

[17]  T. Mang,et al.  Topical δ-aminolevulinic acid for photodynamic therapy of cutaneous carcinomas and cutaneous T cell lymphoma , 1993 .

[18]  M. Waner,et al.  Photodynamic Therapy for Multiple Skin Cancers , 1988, Plastic and reconstructive surgery.

[19]  Michele T. Cooper,et al.  Photodynamic therapy for the treatment of basal cell carcinoma. , 1992, Archives of dermatology.

[20]  H Stepp,et al.  Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.

[21]  K Svanberg,et al.  Photodynamic therapy of non‐melanoma malignant tumours of the skin using topical δ‐amino levulinic acid sensitization and laser irradiation , 1994, The British journal of dermatology.

[22]  W. Hicks,et al.  Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. , 1989, Archives of surgery.

[23]  T. Mang,et al.  Photodynamic therapy in the treatment of Bowen's disease. , 1992, Journal of the American Academy of Dermatology.

[24]  H. Kerl,et al.  Photodynamic therapy in patient with xeroderma pigmentosum , 1991, The Lancet.

[25]  H. Wulf,et al.  Photodynamic therapy with 5‐aminolevulinic acid in the treatment of actinic cheilitis , 1996, The British journal of dermatology.

[26]  H. Hönigsmann,et al.  Photodynamic therapy of epithelial skin tumours using delta‐aminolaevulinic acid and desferrioxamine , 1995, The British journal of dermatology.

[27]  T. Ruzicka,et al.  Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses , 1997, Photodermatology, photoimmunology & photomedicine.

[28]  M. Landthaler,et al.  Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. , 1996, Dermatology.

[29]  M. Stringer,et al.  The variable response of plaque psoriasis after a single treatment with topical 5‐aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.

[30]  G. Goerz,et al.  Ferrochelatase activities in patients with erythropoietic protoporphyria and their families , 1996, The British journal of dermatology.

[31]  G. Stables,et al.  The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. , 1996, The Journal of investigative dermatology.

[32]  M. Berns,et al.  Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative , 1984, Lasers in surgery and medicine.

[33]  D. Ash,et al.  Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.

[34]  F. Figge,et al.  Cancer Detection and Therapy. Affinity of Neoplastic, Embryonic, and Traumatized Tissues for Porphyrins and Metalloporphyrins.∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  H. Kerl,et al.  Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1994, Journal of the American Academy of Dermatology.

[36]  N Kollias,et al.  Fluorescence photography in the evaluation of acne. , 1996, Journal of the American Academy of Dermatology.

[37]  D. V. Ash,et al.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.

[38]  R Marchesini,et al.  Photodynamic therapy by topical meso-tetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas. , 1990, Cancer research.

[39]  J Moan,et al.  DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA , 1995, Photochemistry and photobiology.

[40]  A. Goetz,et al.  Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. , 1995, The Journal of investigative dermatology.

[41]  M Landthaler,et al.  A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. , 1994, Acta dermato-venereologica.

[42]  T. Mang,et al.  An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. , 1993, European journal of cancer.

[43]  R Baumgartner,et al.  Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. , 1994, Urology.

[44]  CLAUDE C. FRAZIER,et al.  PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.

[45]  I. Driver,et al.  Interstitial photodynamic therapy. Clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours. , 1993, British Journal of Cancer.

[46]  P. Robinson,et al.  Photodynamic therapy: a better treatment for widespread Bowen's disease , 1988, The British journal of dermatology.

[47]  J. M. Nauta,et al.  Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications. , 1996, European journal of oral sciences.

[48]  C. Whitehurst,et al.  Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease , 1996, The British journal of dermatology.

[49]  M. Jirsa,et al.  Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)-porphin (TPPS4). , 1996, Journal of photochemistry and photobiology. B, Biology.

[50]  W. Stahl,et al.  Porphyrins Preferentially Accumulate in a Melanoma Following Intravenous Injection of 5-Aminolevulinic Acid , 1997, Biological chemistry.

[51]  J. Nelson,et al.  Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. , 1997, Archives of dermatology.

[52]  S. Waldow,et al.  Photodynamic therapy for treatment of malignant cutaneous lesions , 1987, Lasers in surgery and medicine.

[53]  P Lehmann,et al.  Preferential Relative Porphyrin Enrichment in Solar Keratoses upon Topical Application of ^‐Aminolevulinic Acid Methylester , 1998, Photochemistry and photobiology.

[54]  J. Carruth,et al.  Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[55]  D. Visscher,et al.  Photodynamic Therapy for Treatment of AIDS-Related Oral Kaposi's Sarcoma , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[56]  I. Driver,et al.  Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man. , 1988, British Journal of Cancer.

[57]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.